Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chesterfield, Missouri Clinical Trials

A listing of Chesterfield, Missouri clinical trials actively recruiting patient volunteers.

RESULTS

Found (14) clinical trials

Electrical Acupuncture and Laser Therapy for Low Back Pain

The purpose of the study is to investigate the effects of electroacupuncture and laser therapy to treat chronic low back pain.

Phase

0.0 miles

Learn More »

The Effect of Vibration Therapy on the Bone Density of the Tiba in Patients With Spinal Cord Injury

The purpose of this investigation is to determine the effect of lower limb vibration therapy on bone density in the tibia in patients with spinal cord injury. The second purpose is to assess the neuromuscular junction variability at the motor units of the tibialis anterior muscle after a sequence of ...

Phase

2.43 miles

Learn More »

Standard Process 21 Day Purification Program Project

Elevated low-density lipoprotein (LDL) cholesterol concentrations are a risk factor for cardiovascular diseases. (1) Cholesterol lowering drugs are the most frequently prescribed medications in the U.S. and are known to have muscle, kidney and liver side effects for some users. Recent reviews conclude that benefits outweigh risks reporting statin and ...

Phase

2.43 miles

Learn More »

The Effect of Acupuncture on Blood Pressure and Heart Rate Variability (HRV)

Outcome measurements include blood pressure and heart rate variability.

Phase

2.43 miles

Learn More »

Logan Basic During Pregnancy on Labor and Childbirth

This study will be designed to test if the Logan Basic Technique system of adjusting pregnant women can reduce labor time and increase the ease of labor and delivery as compared to the labor times reported by Kilpatrick and Laros in the obstetric literature. It is proposed that women who ...

Phase

2.43 miles

Learn More »

The Effects of Short Arc Banding

Multifidus muscle is well known and documented to be a segmental spinal stabilizer and postural muscle. (Bajek, Bogduk) Previous studies have shown evidence that patients with low back pain (LBP) present with multifidus muscle atrophy. It has been documented that patients presenting with unilateral back pain demonstrate an ipsilateral state ...

Phase

2.43 miles

Learn More »

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

Double blind study with Lactated Ringers Solution and Lactated Ringers Solution with Arginine soaked for 10 minutes prior to grafting on the coronary arteries.

Phase

2.43 miles

Learn More »

Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

PRIMARY OBJECTIVES: I. To establish the maximum tolerated dose (MTD) for combination therapy pomalidomide/dexamethasone/ixazomib. (Phase I) II. To assess whether the combination of pomalidomide/dexamethasone/ixazomib improves progression-free survival (PFS) relative to pomalidomide/dexamethasone. (Phase II) SECONDARY OBJECTIVES: I. To determine dose-limiting toxicities (DLTs). (Phase I) II. To analyze type and grade of ...

Phase

2.43 miles

Learn More »

Study to Evaluate the Safety and Preliminary Efficacy of IDCT a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

This is a Phase I, firstinhuman, randomized, doubleblind, vehicle and placebo-controlled, parallelgroup, multi-center study in subjects with singlelevel, symptomatic lumbar intervertebral disc degeneration (>6 months) and unresponsive to conservative therapy for at least 3 months. The study will compare single intradiscal injections of high and low dose IDCT with two ...

Phase

2.43 miles

Learn More »

Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

PRIMARY OBJECTIVES: I. To determine the maximum tolerated dose (MTD) and dose limiting toxicities (DLT) of the combinations of brentuximab vedotin and ipilimumab, brentuximab vedotin and nivolumab, and brentuximab vedotin, ipilimumab, and nivolumab. (Phase I) II. To evaluate the complete response (CR) rate for the regimens of brentuximab vedotin and ...

Phase

3.85 miles

Learn More »